Product innovations > White / Technical Paper
Fill form to download now!
Please note that any information that you supply is protected by our Privacy Policy.
Access to all documents and request for further information are available to all users at no cost. In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information may be shared with the owners of that document or information.
Challenge of scaleup of High dose-1
|
The application of oral disintegrating technologies to higher dose actives is a natural extension of this ease of delivery dosage form. A number of companies have marketed products into lower dose therapy < 100 mg using delivery nomenclatures including ODT as well as their own trade mark names. As we enter the next generation of such products, we are seeing more interest in the higher dose 300 mg and higher dosage category of products. Especially in the patient friendly OTC product category
